Round table “Drug labeling: how will the new system affect prices?”
On September 17, at 12:00, the Association of Russian Pharmaceutical Manufacturers and the Komsomolskaya Pravda Publishing House invite to participate in the round table: “Drug labeling: how will the new system affect prices”?
Today, the implementation of such an important task for manufacturers and society as the labeling of medicines is in question. Every day, the number of those who doubt the successful launch of the project, which should start throughout the country from January 1, 2020, is increasing. If serious measures are not taken now, then in a matter of months man-made collapse may occur, associated with the defect of drugs, the consequences of which can be socially dangerous.
The purpose of the experiment is to increase the transparency of the movement and accounting of medicines, to eliminate counterfeit products from circulation. Initially, according to the order of the Government of the Russian Federation of 2015, a phased implementation of an automated system for monitoring drugs was planned. It was also said about the free transfer of data marking codes - in fact, it turned out the opposite. And these costs will fall on the shoulders of patients. Medicines will rise in price, and some will disappear altogether from pharmacy shelves. Manufacturers will be forced to save on everything, and this will inevitably entail job cuts. In addition, it is still not clear what the length of the cryptographic code will be? There is a lack of a clear regulatory framework, so what will happen to the pharmaceutical industry in the near future?
Before the start of the All-Russian labeling, there is less and less time left, and there are more questions every day. What conclusions can be drawn now - in the last months of voluntary participation in the program?
How does a unified automated system for monitoring drug circulation work in practice? How will Drug Movement Monitoring (DMM) affect pricing? Will the patient-consumer suffer? What are the pros, cons and pitfalls of the system? What difficulties did participants encounter during registration and practical participation in the program?
We will summarize the intermediate results of the experiment, analyze the readiness of enterprises, ask hot questions to representatives of the Ministry of Health of the Russian Federation, the Department of Health of Moscow, deputies of the State Duma and the head of the Pharma department of the Advanced Technology Development Center, Sergey Kholkin.
Moderator of the round table - Victor Dmitriev, General Director of the Association of Russian Pharmaceutical Manufacturers (ARPM).
Venue - Press Center of Publishing House "Komsomolskaya Pravda", Old Petrovsko-Razumovsky proezd, 1/23, fifth floor, Blue Hall